Overactivity of the JAK signalling pathway is believed to drive inflammation involved in the development and progression of vitiligo. New 52-week results from a dose-ranging phase 2b study of ...

I always respond positively because maybe they just don’t know or lack knowledge about my skin condition.” Farah admitted ...

A recent study identified three clinically distinct vitiligo profiles on the basis of Vitiligo Patient Priority Outcomes (ViPPO) responses from real-world patient data. Classes with more severe ...

Light therapy is a common treatment that exposes your skin to a type of ultraviolet light that can help stop or slow the progression of active vitiligo and restore your natural skin color.

Vitiligo and albinism may appear similar ... essentially slowing any progression of the disease.

SCENESSE® is being evaluated as a systemic repigmentation therapy for vitiligo patients, with a clinical focus on adolescent (12 years and above) and adult patients with darker skin types ...

Begur & Partners has advised Colossa Ventures LLP on its equity investment in Ahammune Biosciences Private Limited. The ...

At week 24, the ritlecitinib plus nbUVB group saw a higher facial vitiligo severity change from baseline vs. the ritlecitinib-monotherapy group. Similar reductions were seen in body vitiligo severity.

Clarifying that vitiligo is not a contagious disease, Dr Lee said vitiligo cases in Malaysia are at a manageable level. “So far, the progression of vitiligo in Malaysia has remained stable. Thanks to ...